Lipoprotein glomerulopathy with a novel apolipoprotein E variant, APOE Kanto (Asp 151dup).
Akio Yokochi; Akira Matsunaga; Keiko Kanemoto; Naoto Tominaga; Susumu Uda; Takao Saito
CEN case reports, 2024年08月14日

Lipoprotein glomerulopathy with markedly increased arterial stiffness successfully treated with a combination of fenofibrate and losartan: a case report.
Junichiro Kato; Hideo Okonogi; Go Kanzaki; Haruki Katsumata; Yasuyuki Nakada; Makoto Sagasaki; Kazumasa Komine; Kenji Ito; Takao Saito; Akira Matsunaga; Koh Tokutou; Kazuho Honda; Nobuo Tsuboi; Takashi Yokoo
BMC nephrology, 2024年05月20日, 25(1):171 - 171

Emerging resistance to beta-lactams in Pantoea ananatis isolated from an immunocompetent patient with bacteremia.
Michinobu Yoshimura; Chiemi Tokushige; Jun-Ichi Maruyama; Yasumasa Kawano; Hiroyasu Ishikura; Akira Matsunaga; Tohru Takata; Kenji Hiromatsu; Itaru Yanagihara; Atsushi Togawa; Yasushi Takamatsu
Diagnostic microbiology and infectious disease, 2022年04月, 102(4):115633 - 115633

全自動尿中有形成分分析装置UF5000におけるAty.Cと尿細胞診、尿沈渣の比較検討
酒井 瑠美子; 西山 由加李; 永川 翔吾; 合澤 慶昭; 前野 美幸; 木下 美佐栄; 石川 道子; 嶋田 裕史; 松永 彰; 小川 正浩
日本臨床検査医学会誌, 2021年10月, 69(補冊):139 - 139

「シグナスオートLD-IF」改良LOTの基礎的性能評価
勝山 祐人; 斉藤 絢華; 藤波 清香; 矢野 めぐみ; 田中 康宏; 松崎 友絵; 嶋田 裕史; 松永 彰; 小川 正浩
医療検査と自動化, 2021年08月, 46(4):425 - 425

Analysis of the diagnostic capabilities of urinary neutrophil gelatinase-associated lipocalin and serum procalcitonin for acute kidney injury at the early stage of critical care intensive care unit admission.
Yuji Imoto; Ayano Wakasaki; Kumiko Izumida; Hiroshi Shimada; Kumiko Ohkubo; Yasumasa Kawano; Hiroyasu Ishikura; Akira Matsunaga
Journal of clinical laboratory analysis, 2021年07月, 35(7):e23852

A Continuous Murmur as the Only Clinical Sign for Complex Coronary Artery Fistulas Diagnosis.
Tomoki Imaizumi; Kohei Takata; Amane Ike; Yoshiaki Idemoto; Yuhei Shiga; Makoto Sugihara; Akira Matsunaga; Shin-Ichiro Miura
JACC. Case reports, 2021年05月, 3(5):740 - 744

Correction to: Randomized trial of an increased dose of calcium channel blocker or angiotensin II type 1 receptor blocker as an add-on intensive depressor therapy in type 2 diabetes mellitus patients with uncontrolled essential hypertension: the ACADEMIE Study.
Satoshi Imaizumi; Yuhei Shiga; Masahiro Ogawa; Hideto Sako; Yoshihisa Nagata; Akira Matsunaga; Tetsuro Shirotani; Fumihiro Hoshino; Eiji Yahiro; Yuko Uehara; Natsumi Morito; Hiroyuki Tanigawa; Dai Shimono; Mikio Fukushima; Hidekazu Sugihara; Kenji Norimatsu; Takaaki Kusumoto; Keijiro Saku; Shin-Ichiro Miura
Heart and vessels, 2020年04月, 35(4):603 - 604, 査読有り

Variants of Lipid-Related Genes in Adult Japanese Patients with Severe Hypertriglyceridemia.
Akira Matsunaga; Mariko Nagashima; Hideko Yamagishi; Keijiro Saku
Journal of atherosclerosis and thrombosis, 2020年02月29日, 27(12):1264 - 1277, 査読有り

Apolipoprotein E-related glomerular disorders.
Takao Saito; Akira Matsunaga; Megumu Fukunaga; Kiyotaka Nagahama; Shigeo Hara; Eri Muso
Kidney international, 2020年02月, 97(2):279 - 288, 査読有り

Development of risk factor-based scoring system for detection of hypervirulent Klebsiella pneumoniae bloodstream infections.
Atsushi Togawa; Michinobu Yoshimura; Chiemi Tokushige; Akira Matsunaga; Tohru Takata; Yasushi Takamatsu
Gut pathogens, 2020年, 12:34 - 34

Comparison of Two Homogeneous LDL-Cholesterol Assays Using Fresh Hypertriglyceridemic Serum and Quantitative Ultracentrifugation Fractions.
Megumi Yano; Akira Matsunaga; Sadako Harada; Bo Zhang; Emi Kawachi; Mikiko Tadera; Keijiro Saku
Journal of atherosclerosis and thrombosis, 2019年11月01日, 26(11):979 - 988, 査読有り

A case of apolipoprotein E Toyonaka and homozygous apolipoprotein E2/2 showing non-immune membranous nephropathy-like glomerular lesions with foamy changes.
Tamayo Kato; Yasuyuki Ushiogi; Hitoshi Yokoyama; Shigeo Hara; Akira Matsunaga; Eri Muso; Takao Saito
CEN case reports, 2019年05月, 8(2):106 - 111, 査読有り

Randomized trial of an increased dose of calcium channel blocker or angiotensin II type 1 receptor blocker as an add-on intensive depressor therapy in type 2 diabetes mellitus patients with uncontrolled essential hypertension: the ACADEMIE Study.
Satoshi Imaizumi; Yuhei Shiga; Masahiro Ogawa; Hideto Sako; Yoshihisa Nagata; Akira Matsunaga; Tetsuro Shirotani; Fumihiro Hoshino; Eiji Yahiro; Yuko Uehara; Natsumi Morito; Hiroyuki Tanigawa; Dai Shimono; Mikio Fukushima; Hidekazu Sugihara; Kenji Norimatsu; Takaaki Kusumoto; Keijiro Saku; Shin-Ichiro Miura
Heart and vessels, 2019年04月, 34(4):698 - 710, 査読有り

Focal segmental glomerulosclerosis with heterozygous apolipoprotein E5 (Glu3Lys).
Masaru Sasaki; Tetsuhiko Yasuno; Kenji Ito; Akira Matsunaga; Satoshi Hisano; Yasuhiro Abe; Katsuhisa Miyake; Kosuke Masutani; Hitoshi Nakashima; Takao Saito
CEN case reports, 2018年11月, 7(2):225 - 228, 査読有り

A case of lipoprotein glomerulopathy with a rare apolipoprotein E isoform combined with neurofibromatosis type I.
Satoshi Takasaki; Akira Matsunaga; Kensuke Joh; Takao Saito
CEN case reports, 2018年05月, 7(1):127 - 131, 査読有り

Membranous Nephropathy-Like Apolipoprotein E Deposition Disease with Apolipoprotein E Toyonaka (Ser197Cys) and a Homozygous Apolipoprotein E2/2
Megumu Fukunaga; Kiyotaka Nagahama; Michiko Aoki; Akira Shimizu; Shigeo Hara; Akira Matsunaga; Eri Muso; Takao Saito
Case Reports in Nephrology and Dialysis, 2018年03月20日, 8(1):45 - 55, 査読有り

Evaluation of the Time-Dependent Changes and the Vulnerability of Carotid Plaques Using Contrast-Enhanced Carotid Ultrasonography.
Hirofumi Shimada; Toshiyasu Ogata; Koichi Takano; Hiroshi Abe; Toshio Higashi; Takaaki Yamashita; Akira Matsunaga; Tooru Inoue
Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association, 2018年02月, 27(2):321 - 325, 査読有り

A case of nephrotic syndrome showing contemporary presence of apolipoprotein E2 homozygote glomerulopathy and membranous nephropathy-like findings modified by apolipoprotein E Toyonaka.
Hirashima H; Komiya T; Toriu N; Hara S; Matsunaga A; Saito T; Muso E
Clinical nephrology. Case studies, 2018年, 6:45 - 51, 査読有り

A rare case of acute myocardial infarction with a non-specific symptom in a young female with systemic lupus erythematosus.
Tomo Komaki; Shin-Ichiro Miura; Kouki Gondo; Ayumi Nakamura; Amane Ike; Akira Matsunaga; Keijiro Saku
Journal of cardiology cases, 2017年08月, 16(2):56 - 61, 査読有り

A Case of Lipoprotein Glomerulopathy with apoE Chicago and apoE (Glu3Lys) Treated with Fenofibrate
Hitoshi Kodera; Yasuhide Mizutani; Satoshi Sugiyama; Toshio Miyata; Takashi Ehara; Akira Matsunaga; Takao Saito
Case Reports in Nephrology and Dialysis, 2017年07月27日, 7(2):112 - 120, 査読有り

The Change in Body Weight During Hospitalization Predicts Mortality in Patients With Acute Decompensated Heart Failure.
Tomo Komaki; Shin-Ichiro Miura; Tadaaki Arimura; Yuhei Shiga; Joji Morii; Takashi Kuwano; Satoshi Imaizumi; Ken Kitajima; Atsushi Iwata; Natsumi Morito; Eiji Yahiro; Kanta Fujimi; Akira Matsunaga; Keijiro Saku
Journal of clinical medicine research, 2017年03月, 9(3):200 - 206, 査読有り

BK-UM in patients with recurrent ovarian cancer or peritoneal cancer: a first-in-human phase-I study.
Shingo Miyamoto; Fusanori Yotsumoto; Taeko Ueda; Tatsuya Fukami; Ayako Sanui; Kohei Miyata; Sung Ouk Nam; Satoshi Fukagawa; Takahiro Katsuta; Miyako Maehara; Haruhiko Kondo; Daisuke Miyahara; Kyoko Shirota; Toshiyuki Yoshizato; Masahide Kuroki; Hiroaki Nishikawa; Keijiro Saku; Yoshio Tsuboi; Kenji Ishitsuka; Yasushi Takamatsu; Kazuo Tamura; Akira Matsunaga; Toru Hachisuga; Shinsuke Nishino; Takashi Odawara; Kazuhiro Maeda; Sadao Manabe; Toyokazu Ishikawa; Yoshinobu Okuno; Minako Ohishi; Tomoya Hikita; Hiroto Mizushima; Ryo Iwamoto; Eisuke Mekada
BMC cancer, 2017年01月31日, 17(1):89 - 89, 査読有り

CVポートカテーテル留置下で右房内異常構造物を認めた1例
吉峯有香; 岩本恵理子; 小吉里枝; 佐光英人; 森戸夏美; 松本直通; 峰松紀年; 三浦伸一郎; 和田秀一; 松永彰; 朔啓二郎
臨床と研究, 2017年, 94(2):91 - 94

Circadian variations in laboratory measurements of coagulation assays after administration of rivaroxaban or warfarin in patients with nonvalvular atrial fibrillation.
Yuka Hitaka; Masahiro Ogawa; Bo Zhang; Shunichiro Goto; Yoshihisa Nagata; Joji Morii; Satoshi Imaizumi; Tomoo Yasuda; Naomichi Matsumoto; Akira Matsunaga; Keijiro Saku
Journal of cardiology, 2016年12月, 68(6):529 - 535, 査読有り

[Analysis of Hepatitis B Virus Reactivation in Fukuoka University Hospital].
Makiko Yuki; Hiromi Ishida; Kumiko Ohkubo; Hironobu Kawashima; Akira Matsunaga
Rinsho byori. The Japanese journal of clinical pathology, 2016年06月, 64(6):625 - 630, 査読有り

Macrophage Infiltration into the Glomeruli in Lipoprotein Glomerulopathy
Satoshi Takasaki; Kunihiko Maeda; Kensuke Joh; Shu Yamakage; Sachiko Fukase; Toshiyuki Takahashi; Masayuki Suzuki; Akira Matsunaga; Takao Saito
Case Reports in Nephrology and Dialysis, 2015年12月15日, 5(3):204 - 212, 査読有り

Associations between glycated albumin or hemoglobin A1c and the presence of coronary artery disease.
Kenji Norimatsu; Shin-Ichiro Miura; Yasunori Suematsu; Yuhei Shiga; Yuiko Miyase; Ayumi Nakamura; Mayumi Yamada; Akira Matsunaga; Keijiro Saku
Journal of cardiology, 2015年06月, 65(6):487 - 93, 査読有り

薬剤アレルギー同定の効率化に関する基礎的検討―1次スクリーニングとしての細胞動態解析―
安高勇気; 芝口浩智; 黒木政秀; 松永彰; 二神幸次郎
医療薬学, 2015年, 41(1):11 - 17, 査読有り

A novel mutation of CLCNKB in a Japanese patient of Gitelman-like phenotype with diuretic insensitivity to thiazide administration.
Kumiko Ohkubo; Tomoe Matsuzaki; Makiko Yuki; Ryoko Yoshida; Yuichi Terawaki; Akira Maeyama; Hironobu Kawashima; Junko Ono; Toshihiko Yanase; Akira Matsunaga
Meta gene, 2014年12月, 2:342 - 8, 査読有り

異なる臨床症状を呈したTokyo/Maebashi型遺伝子異常によるリポ蛋白糸球体症の母子症例
龍華 章裕; 湊口 俊; 村井 由香里; 川人 瑠衣; 尾関 貴哉; 木田 節; 大山 友香子; 土師 陽一郎; 野村 篤史; 富野 竜人; 志水 英明; 藤田 芳郎; 松永 彰; 斉藤 喬雄
Therapeutic Research, 2014年11月, 35(11):973 - 973

高齢者の発作性心房細動に対し様々な心臓超音波を用いカテーテルアブレーションを施行した1例
長田 芳久; 森井 誠士; 日高 有香; 今泉 聡; 安田 智生; 松本 直通; 小川 正浩; 松永 彰
臨床病理, 2014年10月, 62(補冊):250 - 250

[Nationwide surveillance of parenteral antibiotics containing meropenem activities against clinically isolated strains in 2012].
Keizo Yamaguchi; Yoshikazu Ishii; Kazuhiro Tateda; Morihiro Iwata; Naoki Watanabe; Masaaki Shinagawa; Hiroyuki Kayaba; Masahiko Kimura; Akira Suwabe; Mitsuo Kaku; Yuko Abe; Keiji Kanemitsu; Nobuyuki Taniguchi; Masami Murakami; Shigefumi Maesaki; Toru Kawamura; Fumio Nomura; Masaharu Watanabe; Harushige Kanno; Hajime Horiuchi; Yoko Tazawa; Shigemi Kondo; Shigeki Misawa; Hiromu Takemura; Hideki Nakashima; Takayuki Matsuto; Yoshinori Fujimoto; Shiomi Ishigo; Hirokazu Gotoh; Osamu Watanabe; Tetsuya Yagi; Nami Shimaoka; Hiroshige Mikamo; Yuka Yamagishi; Naohisa Fujita; Toshiaki Komori; Satoshi Ichiyama; Seiji Kawano; Akifumi Nakayama; Fumihiko Nakamura; Hisashi Kohno; Saori Fukuda; Nobuchika Kusano; Motoko Nose; Michiya Yokozaki; Makoto Onodera; Koji Murao; Kiyoshi Negayama; Tatsuya Nishimiya; Hitoshi Miyamoto; Akira Matsunaga; Hisae Yoshimura; Shigeru Kohno; Katsunori Yanagihara; Kazufumi Hiramatsu
The Japanese journal of antibiotics, 2014年04月, 67(2):73 - 107, 査読有り

Topics in lipoprotein glomerulopathy: an overview.
Takao Saito; Akira Matsunaga; Kenji Ito; Hitoshi Nakashima
Clinical and experimental nephrology, 2014年04月, 18(2):214 - 7, 査読有り

Apolipoprotein E mutations: a comparison between lipoprotein glomerulopathy and type III hyperlipoproteinemia.
Akira Matsunaga; Takao Saito
Clinical and experimental nephrology, 2014年04月, 18(2):220 - 4, 査読有り

Lipoprotein glomerulopathy may provide a key to unlock the puzzles of renal lipidosis.
Takao Saito; Akira Matsunaga
Kidney international, 2014年02月, 85(2):243 - 5, 査読有り

Compound Heterozygotes for a Novel Mutation, Apo E1 Nagoya (Arg142Ser) and Apo E2 (Arg158Cys), with Severe Type III Hyperlipoproteinemia and Familial Hypercholesterolemia
Nagahiko Sakuma; Takeshi Hibino; Tomoaki Saeki; Takahiro Nagata; Toru Sato; Noriaki Okuda; Akira Matsunaga; Jun Sasaki
JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2014年, 21(9):983 - 988, 査読有り

Apolipoprotein A-I Mutations and Clinical Evaluation
Akira Matsunaga
The HDL Handbook: Biological Functions and Clinical Implications: Second Edition, 2013年11月07日, :9 - 35, 査読有り

リポ蛋白糸球体症における新たな展開
斉藤喬雄; 松永彰; 中島衡
日本腎臓学会誌, 2013年10月, 55(07):1314 - 1319, 査読有り

Presence of both heterogeneous vancomycin-intermediate resistance and β-lactam antibiotic-induced vancomycin resistance phenotypes is associated with the outcome in methicillin-resistant Staphylococcus aureus bloodstream infection.
Tohru Takata; Motoyasu Miyazaki; Maki Futo; Shuji Hara; Shouichi Shiotsuka; Hidetoshi Kamimura; Hisae Yoshimura; Akira Matsunaga; Takeshi Nishida; Hiroyasu Ishikura; Takahiko Ishikawa; Kazuo Tamura; Brian T Tsuji
Scandinavian journal of infectious diseases, 2013年03月, 45(3):203 - 12, 査読有り

Clinical application of the different cross-reactivities of anti-insulin antibodies to insulin lispro to evaluate endogenous insulin secretion.
Ryoko Yoshida; Kumiko Ohkubo; Yuko Akehi; Sadako Harada; Katsuyuki Shinohara; Hironobu Kawashima; Junko Ono; Akira Matsunaga
Clinica chimica acta; international journal of clinical chemistry, 2013年01月16日, 415:250 - 4, 査読有り

Therapeutic approaches to the regulation of metabolism of high-density lipoprotein. Novel HDL-directed pharmacological intervention and exercise.
Bo Zhang; Emi Kawachi; Shin-Ichiro Miura; Yoshinari Uehara; Akira Matsunaga; Masahide Kuroki; Keijiro Saku
Circulation journal : official journal of the Japanese Circulation Society, 2013年, 77(11):2651 - 63, 査読有り

[Influence of pre-analytical storage conditions on four plasma coagulation molecular markers measured using a STACIA automatic coagulation analyzer].
Masataka Yae; Machiko Sueishi; Yoko Mikami; Misae Kinoshita; Sumiko Hirano; Kiyoko Nakamura; Yuko Futata; Hironobu Kawashima; Kumiko Ohkubo; Hiroyasu Ishikura; Akira Matsunaga
Rinsho byori. The Japanese journal of clinical pathology, 2012年12月, 60(12):1139 - 44, 査読有り

First reported case of hemoglobin lansing in Asia detected by false low oxygen saturation on pulse oximetry
Kenji Ishitsuka; Junji Uchino; Junko Kato; Mikihiro Ikuta; Kentaro Watanabe; Akira Matsunaga; Kazuo Tamura
INTERNATIONAL JOURNAL OF HEMATOLOGY, 2012年06月, 95(6):731 - 732, 査読有り

Methicillin-resistant Staphylococcus aureus bloodstream infections in a Japanese University Hospital between 1987 and 2004.
Tohru Takata; Motoyasu Miyazaki; Haijing Li; Mimi Healy; Stacie Frye; Koko Tanaka; Shuji Hara; Hidetoshi Kamimura; Hisae Yoshimura; Akira Matsunaga; Daiki Ohta; Hiroyasu Ishikura; Kazuo Tamura; Yi-Wei Tang
Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2012年04月, 18(2):199 - 206, 査読有り

第６回 FUKUOKA Fibrate Forum (FFF) 「食前・食後の脂質代謝」
朔啓二郎; 塚本和久; 松永彰; 小林邦久; 仁位隆信; 竹野智彦
Vascular Street, 2012年, 7(4):1 - 6

Reactivity of direct assays for low-density lipoprotein (LDL) cholesterol toward charge-modified LDL in hypercholesterolemia.
Bo Zhang; Emi Kawachi; Akira Matsunaga; Satoshi Imaizumi; Keita Noda; Yoshinari Uehara; Shin-ichiro Miura; Kazuhiko Yoshinaga; Masahide Kuroki; Keijiro Saku
Circulation journal : official journal of the Japanese Circulation Society, 2012年, 76(9):2241 - 8, 査読有り

[The application of fluorescence in situ hybridization to the peripheral-blood preparations].
Mikihiro Ikuta; Akiko Ogami; Yasushi Takamatsu; Kenichi Anami; Ikuo Miura; Junko Kato; Hiromi Ishida; Yuko Futata; Hironobu Kawashima; Akira Matsunaga
Fukuoka igaku zasshi = Hukuoka acta medica, 2011年11月, 102(11):318 - 24, 査読有り

[Hepatitis B tests as screenings for the reactivation of HBV infection at Fukuoka University Hospital].
Tomoe Matsuzaki; Kumiko Ohkubo; Hironobu Kawashima; Akira Matsunaga
Rinsho byori. The Japanese journal of clinical pathology, 2011年06月, 59(6):559 - 64, 査読有り

[I. Metabolic disease: 4. Lipid metabolism abnormalities].
Takao Saito; Satoru Ogahara; Kenji Ito; Akira Matsunaga
Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 2011年05月10日, 100(5):1220 - 6, 査読有り

脂質代謝異常症
斉藤 喬雄; 小河原 悟; 伊藤 建二; 松永 彰
日本内科学会雑誌, 2011年05月, 100(5):1220 - 1226

A Novel Mutation ApoE2 Kurashiki (R158P) in a Patient with Lipoprotein Glomerulopathy
Takehiko Tokura; Seiji Itano; Shinya Kobayashi; Atsunori Kuwabara; Sohachi Fujimoto; Hideyuki Horike; Minoru Satoh; Norio Komai; Naruya Tomita; Akira Matsunaga; Takao Saito; Tamaki Sasaki; Naoki Kashihara
JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2011年, 18(6):536 - 541, 査読有り

Significance of a Novel Apolipoprotein E Variant, ApoE Osaka/Kurashiki, in Lipoprotein Glomerulopathy
Takao Saito; Akira Matsunaga
JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2011年, 18(6):542 - 543, 査読有り

Statins Induce the Gene Expression of Apolipoprotein A5 in HepG2 Cells.
Arishima H; Matsunaga A; Uehara Y; Niimura H; Zhang B; Ohwaki K; Hayashida K; Yoshimizu K; Saku K
Med.Bull.Fukuoka Univ. （福岡大学医学紀要）, 2011年, 38(4):161 - 169

デバイス感染に有効な対処法とは？
松本直通; 松永彰; 朔啓二郎
モダンフィジシャン, 2011年, 31(8):1027

用語解説 T-wave anternans
松本直通; 朔啓二郎; 松永彰
循環器専門医, 2011年, 19(1):72 - 72

SCN5A Mutation Is Associated With Early and Frequent Recurrence of Ventricular Fibrillation in Patients With Brugada Syndrome
Nobuhiro Nishii; Masahiro Ogawa; Hiroshi Morita; Kazufumi Nakamura; Kimikazu Banba; Daiji Miura; Naoko Kumagai; Akira Matsunaga; Hiroshi Kawamura; Shigemi Urakawa; Kohei Miyaji; Masahiro Nagai; Katsumasa Satoh; Koji Nakagawa; Masamichi Tanaka; Shigeki Hiramatsu; Takeshi Tada; Masato Murakami; Satoshi Nagase; Kunihisa Kohno; Kengo Fukushima Kusano; Keijiro Saku; Tohru Ohe; Hiroshi Ito
CIRCULATION JOURNAL, 2010年12月, 74(12):2572 - 2578, 査読有り

Apolipoprotein A-I mutations
Akira Matsunaga; Yoshinari Uehara; Bo Zhang; Keijiro Saku
The HDL Handbook, 2010年, :133 - 151, 査読有り

国試に対する座談会
出石宗仁; 朔啓二郎; 松永彰
烏帽子会會報, 2010年, 49:6 - 11

Efficacy of Additional Amiodarone Therapy in Patients with an Implantable Cardioverter-Defibrillator
Naomichi Matsumoto; Koichiro Kumagai; Masahiro Ogawa; Kunihiro Matsuo; Tomoo Yasuda; Hideo Takashima; Chiharu Mitsutake; Soichi Muraoka; Akira Matsunaga; Shin-ichiro Miura; Keijiro Saku
Journal of Arrhythmia, 2010年, 26(2):103 - 110, 査読有り

第4回 FUKUOKA Fibrate Forum (FFF) パネルディスカッション 「よりよい脂質管理を目指して」
朔啓二郎; 斯波真理子; 松永彰; 秀平キヨミ; 鷲山厚司
Vascular Street, 2010年, 5(10):1 - 6

[Antimicrobial susceptibility patterns of Pseudomonas aeruginosa isolated from 2006 to 2008 in Fukuoka University Hospital].
Hisae Yoshimura; Hiromi To; Chika Narita; Chiemi Tokushige; Tomoko Kakudo; Chiasa Otsubo; Makiko Yuki; Satomi Inamitsu; Shoichi Shiotsuka; Tohru Takata; Kentaro Watanabe; Akira Matsunaga
The Japanese journal of antibiotics, 2009年12月, 62(6):502 - 8, 査読有り

Effects of rosuvastatin on electronegative LDL as characterized by capillary isotachophoresis: the ROSARY Study
Bo Zhang; Akira Matsunaga; David L. Rainwater; Shin-ichiro Miura; Keita Noda; Hiroaki Nishikawa; Yoshinari Uehara; Kazuyuki Shirai; Masahiro Ogawa; Keijiro Saku
JOURNAL OF LIPID RESEARCH, 2009年09月, 50(9):1832 - 1841, 査読有り

Effects of rosuvastatin on electronegative LDL as characterized by capillary isotachophoresis: the ROSARY Study.
Bo Zhang; Akira Matsunaga; David L Rainwater; Shin-Ichiro Miura; Keita Noda; Hiroaki Nishikawa; Yoshinari Uehara; Kazuyuki Shirai; Masahiro Ogawa; Keijiro Saku
Journal of lipid research, 2009年09月, 50(9):1832 - 41, 査読有り

◎パネルディスカッション◎ 第3回FUKUOKA Fibrate Forum (FFF) 『小児肥満と動脈硬化危険因子の関連について』
朔啓二郎; 太田孝男; 松永彰; 山本雄祐
Vascular Street, 2009年, 4(7):1 - 6

Reduction of charge-modified LDL by statin therapy in patients with CHD or CHD risk factors and elevated LDL-C levels: the SPECIAL Study.
Bo Zhang; Shin-ichiro Miura; Daizaburo Yanagi; Keita Noda; Hiroaki Nishikawa; Akira Matsunaga; Kazuyuki Shirai; Atsushi Iwata; Kazuhiko Yoshinaga; Hisashi Adachi; Tsutomu Imaizumi; Keijiro Saku
Atherosclerosis, 2008年12月, 201(2):353 - 9, 査読有り

Reduction of charge-modified LDL by statin therapy in patients with CHD or CHD risk factors and elevated LDL-C levels: The SPECIAL Study
Bo Zhang; Shin-ichiro Miura; Daizaburo Yanagi; Keita Noda; Hiroaki Nishikawa; Akira Matsunaga; Kazuyuki Shirai; Atsushi Iwata; Kazuhiko Yoshinaga; Hisashi Adachi; Tsutomu Imaizumi; Keijiro Saku
ATHEROSCLEROSIS, 2008年12月, 201(2):353 - 359

本態性高血圧患者のメタボリック因子に対するテルミサルタンの効果
上原吉就; 三浦 伸一郎; 藤野正礼; 岩田 敦; 河村 彰; 新村英也; 安田智生; 西川宏明; 松永 彰; 朔 啓二郎
Progress in Medicine, 2008年03月, 28(3):783 - 787, 査読有り

A novel variant apolipoprotein E Okayama in a patient with lipoprotein glomerulopathy
Masaru Kinomura; Hitoshi Sugiyama; Takao Saito; Akira Matsunaga; Ken-ei Sada; Motoko Kanzaki; Yuki Takazawa; Yohei Maeshima; Hiroyuki Yanai; Hirofumi Makino
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2008年02月, 23(2):751 - 756, 査読有り

レジデントダイアリー 循環器内科 CONTRIBUTORS
岩田敦; 河村彰; 熊谷浩一郎; 朔啓二郎; 佐光英人; 白井和之; 西川宏明; 野田慶太; 松尾邦浩; 松永彰; 松本直通; 三浦伸一郎
レジデントダイアリー 循環器内科, 2008年

A novel apolipoprotein E mutation, ApoE Tsukuba (Arg 114 Cys), in lipoprotein glomerulopathy
Masahiro Hagiwara; Kunihiro Yamagata; Tsuneaki Matsunaga; Yoh Arakawa; Joichi Usui; Yoshio Shimizu; Kumi Aita; Michio Nagata; Akio Koyama; Bo Zhang; Akira Mastunaga; Keigiro Saku; Takao Saito
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2008年01月, 23(1):381 - 384, 査読有り

本態性高血圧患者のメタボリック因子に対するテルミサルタンの効果
上原吉就; 三浦伸一郎; 藤野正礼; 岩田敦; 河村彰; 新村英也; 安田智生; 西川宏明; 松永彰; 朔啓二郎
Progress in Medicine, 2008年, 28(3):93 - 97

[Familial HDL deficiency].
Akira Matsunaga; Hiroaki Arishima
Nihon rinsho. Japanese journal of clinical medicine, 2007年07月28日, 65 Suppl 7:608 - 13, 査読有り

Lipoprotein glomerulopathy-like disease in a patient with type III hyperlipoproteinemia due to apolipoprotein E2 (Arg158 Cys)/3 heterozygosity.
Miho Karube; Kimimasa Nakabayashi; Yasunori Fujioka; Ken Yoshihara; Akira Yamada; Akira Matsunaga; Takao Saito
Clinical and experimental nephrology, 2007年06月, 11(2):174 - 179, 査読有り

Strong linkage disequilibrium and association of-1131T > C and c.553G > T polymorphisms of the apolipoprotein A5 gene with hypertriglyceridemia in a Japanese population
Akira Matsunaga; Hiroaki Arishima; Hideya Niimura; Bo Zhang; Yoshinari Uehara; Kazuo Ohwaki; Mie Morita; Kazue Hayashida; Keijiro Saku
CIRCULATION JOURNAL, 2007年05月, 71(5):746 - 752, 査読有り

Strong linkage disequilibrium and association of -1131T>C and c.553G>T polymorphisms of the apolipoprotein A5 gene with hypertriglyceridemia in a Japanese population.
Akira Matsunaga; Hiroaki Arishima; Hideya Niimura; Bo Zhang; Yoshinari Uehara; Kazuo Ohwaki; Mie Morita; Kazue Hayashida; Keijiro Saku
Circulation journal : official journal of the Japanese Circulation Society, 2007年05月, 71(5):746 - 52, 査読有り

新たな日本のエビデンス 「MEGA Studyから学ぶこと」
松永彰; 朔啓二郎
Vascular Street, 2007年, 2(3):1 - 6

本態性高血圧患者の降圧療法におけるオルメサルタンへの切り替え効果
上原吉就; 三浦伸一郎; 岩田敦; 河村彰; 藤野正礼; 松永彰; 朔啓二郎
Progress in Medicine, 2007年, 27(3):639 - 643

遺伝子変異によるLDL-C低下でも冠動脈疾患に罹患しにくくなるのか？
松永彰; 朔啓二郎
Medical Practice, 2007年, 24(2):366

早良区ライフスタイルケアフォーラム パネルディスカッション 医療経営とリスクマネジメントについて 〜病院と開業医の視点から〜
松永彰; 堺孝明; 朔啓二郎
Vascular Street, 2007年, 2(4):1 - 6

城南区Life Style Careフォーラム パネルディスカッション平成18年度診療報酬改定について
松永彰; 堺孝明; 岩田敦; 朔啓二郎
Vascular Street, 2007年, 2(2):1 - 6

Left Ventricular Pseudoaneurysm Following Acute Myocardial Infarction
Niimura H; Mito T; Matsunaga A; Koga S; Akasu K; Morishige N; Tashiro T; Saku K
INTERNAL MEDICINE, 2007年, :1221 - 1223

A novel apolipoprotein E mutation,ApoE Tsukuba(Arg114Cys),in lipoprotein glomerulopathy
Hagiwara M; Yamagata K; Matsunaga A; Arakawa Y; Usui J; Shimizu Y; Aita K; Nagata M; Koyama A; Zhang B; Mastunaga A; Saku K; Saito T
Nephrol Dial Transplant, 2007年, 23(1):381 - 384

Effects of atorvastatin and apoA-I/phosphatidylcholine discs on triglyceride-rich lipoprotein subfractions as characterized by capillary isotachophoresis
Bo Zhang; Ritsuko Katafuchi; Hiroaki Arishima; Akira Matsunaga; Kerry-Anne Rye; Keijiro Saku
CLINICA CHIMICA ACTA, 2006年11月, 373(1-2):55 - 61, 査読有り

Effects of atorvastatin and apoA-Ⅰ/phosphatidylcholine discs on triglyceride-rich lipoprotein subfractions as characterized by capillary isotachophoresis
Zhang B; Katafuchi R; Arishima H; Matsunaga A; Rye K; Saku K
Clinica Chimica Acta, 2006年11月, 373(1-2):55 - 61, 査読有り

Clinical significance of the coronary calcification score by multidetector row computed tomography for the evaluation of coronary stenosis in Japanese patients
Ryoko Mitsutake; Hideya Niimura; Shin-ichiro Miura; Bo Zhang; Atsushi Iwata; Hiroaki Nishikawa; Akira Kawamura; Koichiro Kumagai; Kazuyuki Shirai; Akira Matsunaga; Keijiro Saku
CIRCULATION JOURNAL, 2006年09月, 70(9):1122 - 1127, 査読有り

Clinical significance of the coronary calcification score by multidetector row computed tomography for the evaluation of coronary stenosis in Japanese patients.
Ryoko Mitsutake; Hideya Niimura; Shin-ichiro Miura; Bo Zhang; Atsushi Iwata; Hiroaki Nishikawa; Akira Kawamura; Koichiro Kumagai; Kazuyuki Shirai; Akira Matsunaga; Keijiro Saku
Circulation journal : official journal of the Japanese Circulation Society, 2006年09月, 70(9):1122 - 7, 査読有り

Association between fast-migrating low-density lipoprotein subfraction as characterized by capillary isotachophoresis and intima-media thickness of carotid artery
Bo Zhang; Naoyasu Maeda; Kyoko Okada; Masafumi Tatsukawa; Yasumori Sawayama; Akira Matsunaga; Koichiro Kumagai; Shin-ichiro Miura; Takamitsu Nagao; Jun Hayashi; Keijiro Saku
ATHEROSCLEROSIS, 2006年07月, 187(1):205 - 212, 査読有り

Association between fast-migrating low-density lipoprotein subfraction as characterized by capillary isotachophoresis and intima-media thickness of carotid artery.
Bo Zhang; Naoyasu Maeda; Kyoko Okada; Masafumi Tatsukawa; Yasumori Sawayama; Akira Matsunaga; Koichiro Kumagai; Shin-ichiro Miura; Takamitsu Nagao; Jun Hayashi; Keijiro Saku
Atherosclerosis, 2006年07月, 187(1):205 - 12, 査読有り

Modulating effects of cholesterol feeding and simvastatin treatment on platelet-activating factor acetylhydrolase activity and lysophosphatidylcholine concentration.
Bo Zhang; Ping Fan; Eiso Shimoji; Hiroyuki Itabe; Shin-ichiro Miura; Yoshinari Uehara; Akira Matsunaga; Keijiro Saku
Atherosclerosis, 2006年06月, 186(2):291 - 301, 査読有り

Modulating effects of cholesterol feeding and simvastatin treatment on platelet-activating factor acetylhydrolase activity and lysophosphatidylcholine concentration
B Zhang; P Fan; E Shimoji; H Itabe; S Miura; Y Uehara; A Matsunaga; K Saku
ATHEROSCLEROSIS, 2006年06月, 186(2):291 - 301

Impact of lipoprotein glomerulopathy on the relationship between lipids and renal diseases.
Takao Saito; Akira Matsunaga; Shinichi Oikawa
American journal of kidney diseases : the official journal of the National Kidney Foundation, 2006年02月, 47(2):199 - 211, 査読有り

Long-term effect of nifedipine CR tablet in patients with poor blood pressure control - Comparison with amlodipine
Akira Matsunaga; Hiroaki Arishima; Hideya Niimura; Keijiro Saku
Therapeutic Research, 2006年, 27(3):489 - 495

南区Life Style Careフォーラム
松永彰; 上原吉就; 安田智生; 朔啓二郎
Vascular Street, 2006年, 1(10):1 - 6

Metabolic Cardiology Update Conference(MCUC) June21st,2006 Rome,Italy(Hotel Sheraton Conf & Center)
松永彰; 朔啓二郎
Vascular Street, 2006年, 1(12):1 - 6

メタボリックシンドロームの脂質管理
松永彰; 朔啓二郎
Vascular Street, 2006年, 1(11):1 - 6

Newly developed reconstituted high-density lipoprotein containing sphingosine-1-phosphate induces endothelial tube formation.
河村 彰; 新村 英也; 三浦 伸一郎; 瀬川 波子; 岩田 敦; 西川 宏明; 熊谷 浩一郎; 白井 和之; 松永 彰; 朔 啓二郎
Circ J, 2006年, 194(1):159 - 168

降圧効果不十分例におけるニフェジピンCR錠の長期投与効果；アムロジピンからの変更による比較
松永彰; 有島宏明; 新村英也; 朔啓二郎
THERAPEUTIC RESEARCH, 2006年, 27:489 - 495

コレステロールは夜作られるので、HMG-CoA還元酵阻害薬（スタチン）は夜飲むべきなのか？
松永彰; 朔啓二郎
治療, 2006年, 88(3):701 - 704

高カイロミクロン血症の新しい原因遺伝子：アポＡ５
松永彰; 朔啓二郎
Medical Practice, 2006年, 23(6):1069

Left ventricular pseudoaneurysm following acute myocardial infarction
Hideya Niimura; Takahiro Mito; Akira Matsunaga; Satoshi Koga; Koji Akasu; Noritsugu Morishige; Tadashi Tashiro; Keijiro Saku
INTERNAL MEDICINE, 2006年, 45(21):1221 - 1223, 査読有り

Left ventricular pseudoaneurysm following acute myocardial infarction.
Hideya Niimura; Takahiro Mito; Akira Matsunaga; Satoshi Koga; Koji Akasu; Noritsugu Morishige; Tadashi Tashiro; Keijiro Saku
Internal medicine (Tokyo, Japan), 2006年, 45(21):1221 - 3, 査読有り

Potent capillary isotachophoresis (cITP) for analyzing a marker of coronary heart disease risk and electronegative low-density lipoprotein (LDL) in small dense LDL fraction.
Keita Noda; Bo Zhang; Yoshinari Uehara; Shin-ichiro Miura; Akira Matsunaga; Keijiro Saku
Circulation journal : official journal of the Japanese Circulation Society, 2005年12月, 69(12):1568 - 70, 査読有り

Histochemical characteristics of soleus muscle in angiotensin-converting enzyme gene knockout mice.
Bo Zhang; Naoko Shono; Ping Fan; Setsuko Ando; Huali Xu; Shiro Jimi; Shin-ichiro Miura; Koichiro Kumagai; Khin Mimi Win; Akira Matsunaga; Hiroshi Iwasaski; Keijiro Saku
Hypertension research : official journal of the Japanese Society of Hypertension, 2005年08月, 28(8):681 - 8, 査読有り

Histochemical characteristics of soleus muscle in angiotensin-converting enzyme gene knockout mice
B Zhang; N Shono; P Fan; S Ando; HL Xu; S Jimi; S Miura; K Kumagai; KM Win; A Matsunaga; H Iwasaski; K Saku
HYPERTENSION RESEARCH, 2005年08月, 28(8):681 - 688

A comparative crossover study of the effects of fluvastatin and pravastatin (FP-COS) on circulating autoantibodies to oxidized LDL in patients with hypercholesterolemia
B Zhang; K Noda; A Matsunaga; K Kumagai; K Saku
JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2005年02月, 12(1):41 - 47, 査読有り

シンバスタチン20mg投与の血清脂質低下作用と安全性の検討：プラバスタチン10mgからの変更による比較
松永彰; 有島宏明; 朔啓二郎
PROGRESS IN MEDICINE, 2005年, 25:3101 - 3104

高コレステロール血症治療のアンケート調査
松永彰; 朔啓二郎
Progress in Medicine, 2005年, 25(11):168 - 173

ピオグリタゾン（アクトス）の血清トリグリセリド値低下作用の紹介
松永彰; 朔啓二郎
Medical Practice, 2005年, 22(12):2149

A comparative crossover study of the effects of fluvastatin and pravastatin (FP-COS) on circulating autoantibodies to oxidized LDL in patients with hypercholesterolemia.
Bo Zhang; Keita Noda; Akira Matsunaga; Koichiro Kumagai; Keijiro Saku
Journal of atherosclerosis and thrombosis, 2005年, 12(1):41 - 7, 査読有り

Evaliation of Arterial Elasticity by a Pulse Contour Analysis:A One-Year Follow-Up
Takeuchi K; Matsunaga A; Noda K; Idishi M; Zhang B; Urata H; Morishige N; Tashiro T; Saku K
Med Bull Fukuoka Univ, 2005年, 32(2):27 - 31

[Apolipoprotein E and apolipoprotein E phenotype].
Akira Matsunaga
Nihon rinsho. Japanese journal of clinical medicine, 2004年12月, 62 Suppl 12:114 - 6, 査読有り

Genetic analysis of Brugada syndrome in Western Japan: two novel mutations.
Hideya Niimura; Akira Matsunaga; Koichiro Kumagai; Kazuo Ohwaki; Masahiro Ogawa; Hiroo Noguchi; Kazue Yonemura; Keijiro Saku
Circulation journal : official journal of the Japanese Circulation Society, 2004年08月, 68(8):740 - 6, 査読有り

Genetic analysis of Brugada syndrome in western Japan - Two novel mutations
H Niimura; A Matsunaga; K Kumagai; K Ohwaki; M Ogawa; H Noguchi; K Yonemura; K Saku
CIRCULATION JOURNAL, 2004年08月, 68(8):740 - 746

A novel two nucleotide deletion in the apolipoprotein A-I gene, apoA-I Shinbashi, associated with high density lipoprotein deficiency, corneal opacities, planar xanthomas, and premature coronary artery disease
Katsunori Ikewaki; Akira Matsunaga; Hua Han; Hisayuki Watanabe; Akira Endo; Jun-Ichiro Tohyama; Mamoru Kuno; Jun-Ichi Mogi; Ken-Ichi Sugimoto; Norio Tada; Jun Sasaki; Seibu Mochizuki
Atherosclerosis, 2004年, 172(1):39 - 45

炎症が介入する動脈硬化とその治療戦略
朔啓二郎; 松永彰; 三浦伸一郎; 熊谷浩一郎; 辻恵美子; 張波; 吉永一彦; 浦田秀則; 清永明
福岡大学研究推進部ニュース＆レポート Research, 2004年, 9(4):36 - 38

高齢にて発見された巨大左房粘液腫の一例
今泉聡; 三浦伸一郎; 安田智生; 坂上明彦; 芝野竜一; 松尾邦浩; 田代忠; 木村道生; 松永彰; 朔啓二郎
臨床と研究, 2004年, 81(10):100 - 104

追加療法で心不全が劇的に改善した拡張型心筋症の一例
高宮陽介; 三浦伸一郎; 森憲; 上原吉就; 西川宏明; 白井和之; 松尾邦浩; 福田圭介; 松永彰; 朔啓二郎
臨床と研究, 2004年, 81(6):165 - 169

病変診断にマルチスライスCTが有用であった急性心筋梗塞の一例
新村英也; 三浦伸一郎; 光武良晃; 平田巧; 大和勇三; 松崎通孝; 重森慎司; 松永彰; 朔啓二郎
臨床と研究, 2004年, 81(10):108 - 112

家族性高脂血症への対応
松永彰; 朔啓二郎
治療, 2004年, 86:758 - 760

Human chymase expression in a mice induces mild hypertension with left ventricular hypertrophy
T Koga; H Urata; Y Inoue; T Hoshino; T Okamoto; A Matsunaga; M Suzuki; J Miyazaki; M Ideishi; K Arakawa; K Saku
HYPERTENSION RESEARCH, 2003年09月, 26(9):759 - 768

Human chymase expression in a mice induces mild hypertension with left ventricular hypertrophy.
Takafumi Koga; Hidenori Urata; Yukiko Inoue; Takafumi Hoshino; Takehiro Okamoto; Akira Matsunaga; Misao Suzuki; Junichi Miyazaki; Munehito Ideishi; Kikuo Arakawa; Keijiro Saku
Hypertension research : official journal of the Japanese Society of Hypertension, 2003年09月, 26(9):759 - 68, 査読有り

A Case of Fulminant Myocarditis Successfully Treated with Percutaneous Cardiopulmonary Support (PCPS)
Sugihara M; Matsunaga A; Matsuo K; Serikawa T; Mori T; Tsuchiya Y; Oda S; Saku K
Med.Bull.Fukuoka Univ., 2003年, 30(4):259 - 264

Recurrent Ventricular Fibrillation in a Patient with Variant Angina Treated with an Implantable Cardioverter Defibrillator - a Case Report
Esaki T; Matsunaga A; Niimura H; Mori K; Arishima H; Ogawa M; Noguchi H; Yamanouchi Y; Kumagai K; Saku K
Med.Bull.Fukuoka Univ., 2003年, 30(4):265 - 268

Antioxidative effects of fluvastatin on superoxide anion activated by angiotensin II in human aortic smooth muscle cells.
Mari Kugi; Akira Matsunaga; Junko Ono; Kikuo Arakawa; Jun Sasaki
Cardiovascular drugs and therapy, 2002年05月, 16(3):203 - 7, 査読有り

Recombinant proapoA-I(Lys107del) shows impaired lipid binding associated with reduced binding to plasma high density lipoprotein
W Huang; A Matsunaga; W Li; H Han; A Hoang; M Kugi; T Koga; D Sviridov; N Fidge; J Sasaki
ATHEROSCLEROSIS, 2001年11月, 159(1):85 - 91, 査読有り

A giant left ventricular thrombus in a patient with acute myocardial infarction - A case report
H Hirano; M Takao; J Nomoto; A Matsunaga; Y Tsuchiya; M Ideishi; K Saku
ANGIOLOGY, 2001年06月, 52(6):429 - 432, 査読有り

高HDL血症
松永 彰; 朔啓二郎
臨床と研究, 2001年, 78(5):52 - 55

家族性高コレステロール血症の治療
松永 彰; 朔啓二郎
日本医事新報, 2001年, No.4041:92 - 93

アポA-I遺伝子異常とHDL代謝
松永 彰; 朔啓二郎
循環器科, 2001年, 50:443 - 450

Marked elevation in serum apolipoprotein E in a case of heterozygous cholesteryl ester transfer protein deficiency
S Hirayama; J Kobayashi; K Taira; M Hikita; H Bujo; N Morisaki; A Matsunaga; J Sasaki; Y Saito
CLINICA CHIMICA ACTA, 2000年11月, 301(1-2):55 - 64, 査読有り

In vivo and in vitro evidence for the glycoxidation of low density lipoprotein in human atherosclerotic plaques
Y Imanaga; N Sakata; S Takebayashi; A Matsunaga; J Sasaki; K Arakawa; R Nagai; S Horiuchi; H Itabe; T Takano
ATHEROSCLEROSIS, 2000年06月, 150(2):343 - 355, 査読有り

Marked decrease in plasma apolipoprotein A-I and high density lipoprotein-cholesterol in a case with Werner syndrome
J Kobayashi; S Murano; K Yokote; S Mori; A Matsunaga; J Sasaki; K Takahashi; H Bujo; Y Saito
CLINICA CHIMICA ACTA, 2000年03月, 293(1-2):63 - 73, 査読有り

A single amino acid deletion in the carboxy terminal of apolipoprotein A-I impairs lipid binding and cellular interaction
W Huang; J Sasaki; A Matsunaga; H Han; W Li; T Koga; M Kugi; S Ando; K Arakawa
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2000年01月, 20(1):210 - 216, 査読有り

Structural and functional properties of apolipoprotein A-I mutants.
Sasaki J; Matsunaga A; Huang W; Han H; Li W; Kugi M; Koga T
J Atheroscler Thromb., 2000年, 7:67 - 70, 査読有り

Association of a novel 3-amino acid deletion mutation of apolipoprotein E (Apo E Tokyo) with lipoprotein glomerulopathy
K Konishi; T Saruta; S Kuramochi; S Oikawa; T Saito; H Han; A Matsunaga; J Sasaki
NEPHRON, 1999年11月, 83(3):214 - 218

A novel 18-amino acid deletion in apolipoprotein E associated with lipoprotein glomerulopathy
M Ando; J Sasaki; H Hua; A Matsunaga; K Uchida; K Jou; S Oikawa; T Saito; H Nihei
KIDNEY INTERNATIONAL, 1999年10月, 56(4):1317 - 1323, 査読有り

A novel apolipoprotein E mutation, E2 (Arg25Cys), in lipoprotein glomerulopathy
A Matsunaga; J Sasaki; T Komatsu; K Kanatsu; E Tsuji; K Moriyama; T Koga; K Arakawa; S Oikawa; T Saito; T Kita; T Doi
KIDNEY INTERNATIONAL, 1999年08月, 56(2):421 - 427, 査読有り

Effects of low-intensity aerobic training on the high-density lipoprotein cholesterol concentration in healthy elderly subjects
Y Sunami; M Motoyama; F Kinoshita; Y Mizooka; K Sueta; A Matsunaga; J Sasaki; H Tanaka; M Shindo
METABOLISM-CLINICAL AND EXPERIMENTAL, 1999年08月, 48(8):984 - 988, 査読有り

A novel mutant, apoA-I Nichinan (Glu235 -> 0), is associated with low HDL cholesterol levels and decreased cholesterol efflux from cells
H Han; J Sasaki; A Matsunaga; H Hakamata; W Huang; M Ageta; T Taguchi; T Koga; M Kugi; S Horiuchi; K Arakawa
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1999年06月, 19(6):1447 - 1455, 査読有り

Compound heterozygosity for an apolipoprotein A1 gene promoter mutation and a structural nonsense mutation with apolipoprotein A1 deficiency
A Matsunaga; J Sasaki; H Han; W Huang; M Kugi; T Koga; S Ichiki; T Shinkawa; K Arakawa
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1999年02月, 19(2):348 - 355

Novel homozygous missense mutation in the apo A-I gene with apo A-I deficiency
W Huang; J Sasaki; A Matsunaga; H Nanimatsu; K Moriyama; H Han; M Kugi; T Koga; K Yamaguchi; K Arakawa
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1998年03月, 18(3):389 - 396

Effects of monatepil, a novel calcium antagonist with alpha(1)-adrenergic blocking activity, on the low-density lipoprotein receptor in human skin fibroblasts
A Matsunaga; T Inoue; T Koga; K Mori; M Kugi; J Sasaki; K Arakawa
CARDIOVASCULAR DRUGS AND THERAPY, 1997年12月, 11(6):747 - 750

Apolipoprotein E Sendai (arginine 145->proline): A new variant associated with lipoprotein glomerulopathy
S Oikawa; A Matsunaga; T Saito; H Sato; T Seki; K Hoshi; K Hayasaka; H Kotake; H Midorikawa; A Sekikawa; S Hara; K Abe; T Toyota; H Jingami; H Nakamura; J Sasaki
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1997年05月, 8(5):820 - 823, 査読有り

A cysteine-containing truncated apo A-I variant associated with HDL deficiency
K Moriyama; J Sasaki; Y Takada; A Matsunaga; J Fukui; JJ Albers; K Arakawa
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1996年12月, 16(12):1416 - 1423, 査読有り

Characterization of a novel variant of apolipoprotein E, E2 Fukuoka (Arg-224->Gln) in a hyperlipidemic patient with xanthomatosis
K Moriyama; J Sasaki; Y Takada; F Arakawa; A Matsunaga; Y Ito; K Arakawa
BIOCHIMICA ET BIOPHYSICA ACTA-LIPIDS AND LIPID METABOLISM, 1996年06月, 1301(3):185 - 190

Identification of two apolipoprotein variants, A-I Karatsu (Tyr 100->His) and A-I Kurume (His 162->Gln)
K Moriyama; J Sasaki; A Matsunaga; Y Takada; M Kagimoto; K Arakawa
CLINICAL GENETICS, 1996年02月, 49(2):79 - 84

Identification of two apolipoprotein variants, A-I Kaho (Asp 51-->Val) and A-I Lys 107 deletion.
Moriyama K; Sasaki J; Matsunaga A; Arakawa K
J Atheroscler Thromb., 1996年, 3(1):12 - 16

Apolipoprotein A-I gene promoter polymorphism in patients with coronary artery disease and healthy controls
A Matsunaga; J Sasaki; T Mori; K Moriyama; K Nishi; K Hidaka; K Arakawa
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 1995年12月, 5(4):269 - 275, 査読有り

2 NOVEL POINT MUTATIONS IN THE LECITHIN-CHOLESTEROL ACYLTRANSFERASE (LCAT) GENE RESULTING IN LCAT DEFICIENCY - LCAT (G(873) DELETION) AND LCAT (GLY(344)-]SER)
K MORIYAMA; J SASAKI; F ARAKAWA; N TAKAMI; E MAEDA; A MATSUNAGA; Y TAKADA; K MIDORIKAWA; T YANASE; G YOSHINO; SM MARCOVINA; JJ ALBERS; K ARAKAWA
JOURNAL OF LIPID RESEARCH, 1995年11月, 36(11):2329 - 2343, 査読有り

FAMILIAL HYPOBETALIPOPROTEINEMIA ASSOCIATED WITH HYPOTHYROIDISM
K MORIYAMA; Y TAKADA; K ARAKI; A MATSUNAGA; J SASAKI; K ARAKAWA
INTERNAL MEDICINE, 1995年09月, 34(9):879 - 882, 査読有り

POPULATION FREQUENCY OF APOLIPOPROTEIN E5 (GLU3-]LYS) AND E7 (GLU244-]LYS, GLU245-]LYS) VARIANTS IN WESTERN JAPAN
A MATSUNAGA; J SASAKI; K MORIYAMA; F ARAKAWA; Y TAKADA; K NISHI; K HIDAKA; K ARAKAWA
CLINICAL GENETICS, 1995年08月, 48(2):93 - 99, 査読有り

EFFECTS OF FLUVASTATIN, A NEW INHIBITOR OF HMG-COA REDUCTASE, AND NICERITROL ON SERUM-LIPIDS, LIPOPROTEINS AND CHOLESTEROL ESTER TRANSFER ACTIVITY IN PRIMARY HYPERCHOLESTEROLEMIC PATIENTS
J SASAKI; K YAMAMOTO; S KOBORI; Y SETOGUCHI; Y SATO; A MATSUNAGA; M SHICHIRI; T SAKAI; S KONO; K ARAKAWA
INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 1995年07月, 33(7):420 - 426, 査読有り

AN APOLIPOPROTEIN CIII MARKER ASSOCIATED WITH HYPERTRIGLYCERIDEMIA IN CAUCASIANS ALSO CONFERS INCREASED RISK IN A WEST JAPANESE POPULATION
Q ZENG; M DAMMERMAN; Y TAKADA; A MATSUNAGA; JL BRESLOW; J SASAKI
HUMAN GENETICS, 1995年04月, 95(4):371 - 375, 査読有り

SERUM GLYCOPROTEINS AND SEVERITY OF CORONARY ATHEROSCLEROSIS
T MORI; J SASAKI; H KAWAGUCHI; K HANDA; Y TAKADA; A MATSUNAGA; S KONO; K ARAKAWA
AMERICAN HEART JOURNAL, 1995年02月, 129(2):234 - 238, 査読有り

A PROCEDURE FOR IMPROVING THE NONPHARMACOLOGICAL MANAGEMENT OF THE LIFE-STYLE OF HYPERTENSIVE PATIENTS - COMPUTERIZED APPROACH - THE HEART SMART PROGRAM
J SASAKI; M NAGANO; T HAYASHI; A MATSUNAGA; H TANAKA; A KIYONAGA; S TSUTSUMI; K ARAKAWA
ACTA THERAPEUTICA, 1995年, 21(1):27 - 46, 査読有り

CHARACTERIZATION OF 2 NEW HUMAN APOLIPOPROTEIN-A-I VARIANTS - APOLIPOPROTEIN-A-I TSUSHIMA (TRP-108-]ARG) AND A-I-HITA (ALA-95-]ASP)
K ARAKI; J SASAKI; A MATSUNAGA; Y TAKADA; K MORIYAMA; K HIDAKA; K ARAKAWA
BIOCHIMICA ET BIOPHYSICA ACTA-LIPIDS AND LIPID METABOLISM, 1994年10月, 1214(3):272 - 278, 査読有り

PRAVASTATIN-INDUCED CHANGES IN RECEPTOR-MEDIATED METABOLISM OF LOW-DENSITY-LIPOPROTEIN IN GUINEA-PIGS
A MATSUNAGA; J SASAKI; K HIDAKA; Y TAKADA
ARTERY, 1994年, 21(2):94 - 113, 査読有り

PLASMIN AND THROMBIN INHIBITORS IN ESSENTIALLY UNTREATED PATIENTS WITH CORONARY-ARTERY SPASM
K HANDA; K KIMOTO; H KAWAGUCHI; T MORI; A MATSUNAGA; J SASAKI; K ARAKAWA
INTERNATIONAL JOURNAL OF CARDIOLOGY, 1993年12月, 42(3):263 - 267, 査読有り

Detection of a point mutation in cholesteryl ester transfer protein gene by polymerase chain reaction-mediated site-directed mutagenesis
Akira Matsunaga; Keiichi Araki; Kengo Moriyama; Koichi Handa; Fumiko Arakawa; Kayo Nishi; Jun Sasaki; Kikuo Arakawa
Biochimica et Biophysica Acta (BBA)/Lipids and Lipid Metabolism, 1993年02月10日, 1166(1):131 - 134, 査読有り

DETECTION OF A POINT MUTATION IN CHOLESTERYL ESTER TRANSFER PROTEIN GENE BY POLYMERASE CHAIN REACTION-MEDIATED SITE-DIRECTED MUTAGENESIS
A MATSUNAGA; K ARAKI; K MORIYAMA; K HANDA; F ARAKAWA; K NISHI; J SASAKI; K ARAKAWA
BIOCHIMICA ET BIOPHYSICA ACTA, 1993年02月, 1166(1):131 - 134

Hypotensive effects and influence on serum lipids of SQ29,852, a new angiotensin converting enzyme inhibitor, in patients with essential hypertension: A comparison with atenolol
J. Sasaki; S. Koga; K. Kato; M. Takii; K. Sakai; K. Kawasaki; M. Kagimoto; Y. Doi; K. Takada; A. Sakaue; A. Matsunaga; K. Saku; K. Handa; T. Komazawa; K. Arakawa
International Journal of Clinical Pharmacology Therapy and Toxicology, 1993年, 31(2):83 - 88, 査読有り

Apolipoprotein E1 Lys-146 → Glu with type III hyperlipoproteinemia
Kengo Moriyama; Jun Sasaki; Akira Matsunaga; Fumiko Arakawa; Yoichi Takada; Keiichi Araki; Shuji Kaneko; Kikuo Arakawa
Biochimica et Biophysica Acta (BBA)/Lipids and Lipid Metabolism, 1992年09月22日, 1128(1):58 - 64, 査読有り

Apolipoprotein E1 Lys-146→Glu with type III hyperlipoproteinemia.
Moriyama K; Sasaki J; Matsunaga A; Arakawa F; Takada Y; Araki K; Kaneko S; Arakawa K
Biochim Biophys Acta, 1992年09月, 1128(1):58 - 64

EFFECTS OF AROTINOLOL ON EXERCISE CAPACITY AND HUMORAL-FACTORS DURING EXERCISE IN NORMAL SUBJECTS
T MORI; K HANDA; Y TERAO; H TANAKA; A KIYONAGA; M SHINDO; A MATSUNAGA; J SASAKI; K ARAKAWA
CARDIOVASCULAR DRUGS AND THERAPY, 1992年08月, 6(4):387 - 390

Different coagulability and fibrinolytic activity during exercise depending on exercise intensities
Koichi Handa; Yasunori Terao; Tsukasa Mori; Hiroaki Tanaka; Akira Kiyonaga; Akira Matsunaga; Jun Sasaki; Munehiro Shindo; Kikuo Arakawa
Thrombosis Research, 1992年06月01日, 66(5):613 - 616, 査読有り

EFFECTS OF NICERITROL ON LEVELS OF SERUM-LIPIDS, LIPOPROTEIN(A), AND FIBRINOGEN IN PATIENTS WITH PRIMARY HYPERCHOLESTEROLEMIA
A MATSUNAGA; K HANDA; T MORI; K MORIYAMA; K HIDAKA; M YUKI; J SASAKI; K ARAKAWA
ATHEROSCLEROSIS, 1992年06月, 94(2-3):241 - 248, 査読有り

ADMINISTRATION OF SLOW-RELEASE NIFEDIPINE DOES NOT AFFECT LACTATE THRESHOLD, HORMONE-RELEASE DURING EXERCISE, AND QUALITY-OF-LIFE IN NORMAL SUBJECTS
K HANDA; T MORI; H TANAKA; Y TAKADA; A MATSUNAGA; A KIYONAGA; M SHINDO; J SASAKI; K ARAKAWA
CARDIOVASCULAR DRUGS AND THERAPY, 1992年02月, 6(1):85 - 90, 査読有り

EFFECTS OF PROBUCOL ON LOW-DENSITY-LIPOPROTEIN CATABOLISM IN GUINEA-PIGS
K HIDAKA; Y TAKADA; A MATSUNAGA; J SASAKI; K ARAKAWA
ARTERY, 1992年, 19(3):162 - 176, 査読有り

COMPARISON OF SERUM-LIPID, APOLIPOPROTEIN AND LIPOPROTEIN LEVELS OF ACTIVE AND INACTIVE ELDERLY MEN IN A NURSING-HOME
J SASAKI; T INOUE; T MORI; K KITAJIMA; A MATSUNAGA; Y TAKADA; K ARAKI; K KAWASAKI; K ARAKAWA
JOURNAL OF CLINICAL AND EXPERIMENTAL GERONTOLOGY, 1992年, 14(2):103 - 109, 査読有り

BUNAZOSIN ENHANCES RECEPTOR-MEDIATED ENDOCYTOSIS OF LOW-DENSITY LIPOPROTEINS
A MATSUNAGA; K HIDAKA; J SASAKI; K ARAKAWA
ARTERY, 1992年, 19(6):307 - 317, 査読有り

EFFECTS OF CAPTOPRIL ON OPIOID-PEPTIDES DURING EXERCISE AND QUALITY-OF-LIFE IN NORMAL SUBJECTS
K HANDA; J SASAKI; H TANAKA; A KIYONAGA; A MATSUNAGA; M SHINDO; K ARAKAWA
AMERICAN HEART JOURNAL, 1991年11月, 122(5):1389 - 1394, 査読有り

EFFECT OF SIMVASTATIN ON RECEPTOR MEDIATED METABOLISM OF LOW-DENSITY-LIPOPROTEIN IN GUINEA-PIGS
A MATSUNAGA; J SASAKI; Y TAKADA; K HIDAKA; K ARAKAWA
ATHEROSCLEROSIS, 1991年09月, 90(1):31 - 37, 査読有り

EFFECTS OF GAMMA-ORYZANOL ON SERUM-LIPIDS AND APOLIPOPROTEINS IN DYSLIPIDEMIC SCHIZOPHRENICS RECEIVING MAJOR TRANQUILIZERS
J SASAKI; Y TAKADA; K HANDA; M KUSUDA; Y TANABE; A MATSUNAGA; K ARAKAWA
CLINICAL THERAPEUTICS, 1990年05月, 12(3):263 - 268, 査読有り

PERTUSSIS TOXIN AND H-7 DISTINGUISH MECHANISMS INVOLVED IN EICOSANOID RELEASE FROM LIPOPOLYSACCHARIDE-PRIMED MACROPHAGES - EICOSANOID RELEASE FROM LIPOPOLYSACCHARIDE-PRIMED MACROPHAGES
A MATSUNAGA; BC MILLER; GL COTTAM
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1990年02月, 187(3):599 - 603, 査読有り

DEHYDROISOANDROSTERONE PREVENTION OF AUTOIMMUNE-DISEASE IN NZB W F1-MICE - LACK OF AN EFFECT ON ASSOCIATED IMMUNOLOGICAL ABNORMALITIES
A MATSUNAGA; BC MILLER; GL COTTAM
BIOCHIMICA ET BIOPHYSICA ACTA, 1989年09月, 992(3):265 - 271, 査読有り

EPITOPE MAPPING OF THE CARCINOEMBRYONIC ANTIGEN BY MONOCLONAL-ANTIBODIES AND ESTABLISHMENT OF A NEW IMPROVED RADIOIMMUNOASSAY SYSTEM
M KUROKI; F ARAKAWA; H HIGUCHI; A MATSUNAGA; N OKAMOTO; K TAKAKURA; Y MATSUOKA
JAPANESE JOURNAL OF CANCER RESEARCH, 1987年04月, 78(4):386 - 396, 査読有り

ANTIGENIC HETEROGENEITY OF CARCINOEMBRYONIC ANTIGEN IN THE CIRCULATION DEFINED BY MONOCLONAL-ANTIBODIES AGAINST THE CARBOHYDRATE MOIETY OF CARCINOEMBRYONIC ANTIGEN AND CLOSELY RELATED ANTIGENS
A MATSUNAGA; M KUROKI; H HIGUCHI; F ARAKAWA; K TAKAKURA; N OKAMOTO; Y MATSUOKA
CANCER RESEARCH, 1987年01月, 47(1):56 - 61, 査読有り

ANTIGENIC ALTERATIONS OF CARCINOEMBRYONIC ANTIGEN INVOLVED IN THE SECRETION FROM VARIOUS HUMAN-TUMOR CELL-LINES
S ICHIKI; M KUROKI; A MATSUNAGA; F ARAKAWA; N OKAMOTO; Y MATSUOKA
JAPANESE JOURNAL OF CANCER RESEARCH, 1986年10月, 77(10):1005 - 1011, 査読有り

PRODUCTION OF IMMUNOREACTIVE CALCITONIN AND SOME OTHER TUMOR-MARKERS BY ESTABLISHED HUMAN CARCINOMA CELL-LINES
S ICHIKI; M KUROKI; A MATSUNAGA; M KUROKI; Y MATSUOKA
JAPANESE JOURNAL OF CANCER RESEARCH, 1986年03月, 77(3):270 - 275, 査読有り

Monoclonal抗体によるCEA分子の糖鎖構造の解析：既知のCEA関連抗原以外の物質との交差反応性
松永 彰; 黒木政秀; 樋口 浩; 荒川文子; 岡本直美; 松岡雄治
腫瘍マーカー研究会誌, 1986年, 1(1):249 - 252, 査読有り

Monoclonal抗体によるより癌特異的なCEA測定系確立の試み
黒木政秀; 荒川文子; 高倉享子; 岡本直美; 松永 彰; 松岡雄治
腫瘍マーカー研究会誌, 1986年, 1(1):253 - 256, 査読有り

CEAの基礎
松岡雄治; 黒木政秀; 一木貞徳; 松永彰
臨床病理, 1986年, 34(4):372 - 377, 査読有り

腫瘍マーカーの検出法と臨床応用ー癌胎児性蛋白ー
松永彰; 黒木政秀; 松岡雄治
臨床成人病, 1986年, 16(6):795 - 800, 査読有り

FURTHER COMPARATIVE STUDIES ON CHEMICAL-PROPERTIES OF CARCINOEMBRYONIC ANTIGEN IN TUMOR-TISSUES AND CLOSELY RELATED ANTIGENS IN ADULT FECES AND MECONIUM
Y KOGA; M KUROKI; A MATSUNAGA; T SHINODA; T TAKAYASU; Y MATSUOKA
MOLECULAR IMMUNOLOGY, 1985年, 22(1):67 - 73, 査読有り

Monoclonal抗体で証明された血中CEA分子の抗原的多様性
松永 彰; 黒木政秀; 古賀芳子; 黒木 求; 一木貞徳; 松岡雄治
最新医学, 1985年, 40(6):1320 - 1321, 査読有り

種々の臓器由来の樹立癌細胞株により産生されるカルシトニンの比較解析
一木貞徳; 黒木政秀; 黒木 求; 松永 彰; 松岡雄治
最新医学, 1985年, 40(6):1289 - 1290, 査読有り

Carcinoembryonic antigen (CEA) (in Japanese)
松永彰; 黒木政秀; 松岡雄治
月刊医学と薬学, 1985年, 14(3):611 - 618, 査読有り

Monoclonal抗体によるCarcinoembryonic Antigen (CEA)の微細な抗原構造の解析
黒木政秀; 松永 彰; 黒木 求; 古賀芳子; 松岡雄治
最新医学, 1984年, 39(3):591 - 592, 査読有り

Successful Catheter Ablation of Two Distinct Premature Ventricular Complexes Arising from Right Ventricular Outflow Tract Guided by EnSite NavX 3-D Mapping System with Multielectrode Basket Catheter
MATSUMOTO Naomichi; OGAWA Masahiro; MORII Joji; NAGATA Yoshihisa; IMAIZUMI Satoshi; MATSUNAGA Akira; SAKU Keijiro
福岡大学医学紀要 = Medical bulletin of Fukuoka University, 2017年03月, 44(1):35 - 40

臨牀指針 CVポートカテーテル留置下で右房内異常構造物を認めた1例
吉峯 有香; 岩本 恵理子; 小吉 里枝; 佐光 英人; 森戸 夏美; 松本 直道; 峰松 紀年; 三浦 伸一郎; 和田 秀一; 松永 彰; 朔 啓二郎
臨牀と研究 = The Japanese journal of clinical and experimental medicine, 2017年02月, 94(2):229 - 232

Comparison of circadian laboratory measurements of coagulation assays between administrations of rivaroxaban and warfarin in patients with non-valvular atrial fibrillation
Y. Hitaka; M. Ogawa; S. Goto; Y. Nagata; J. Morii; S. Imaizumi; T. Yasuda; N. Matsumoto; A. Matsunaga; K. Saku
EUROPEAN HEART JOURNAL, 2015年08月, 36:225 - 225

Paradoxical Nocturnal Sympathetic Activation and Spontaneous Ventricular Fibrillation in Resuscitated Patients Without Apparent Structural Heart Diseases
Naoko Kumagai; Masahiro Ogawa; Rie Koyoshi; Joji Mrii; Hideo Takashima; Tomoo Yasuda; Naomichi Matsumoto; Kunihiro Matsuo; Akira Matsunaga; Keijiro Saku
CIRCULATION, 2012年11月, 126(21)

Current status of homogeneous assays for LDL-cholesterol: Comparison with beta-quantification method and Friedewald formula
Akira Matsunaga; Sadako Harada
Japanese Journal of Clinical Chemistry, 2012年10月, 41(4):303 - 309

Association between Eas index by tissue Doppler imaging and ventricular stiffness index or ventriculoarterial interaction in patients with preserved left ventricular ejection fraction
H. Sako; S. Miura; S. Furuyama; A. Matsunaga; K. Saku
EUROPEAN HEART JOURNAL, 2012年08月, 33:728 - 728

検査相談室活動報告(2007年度〜2009年度)
田代 博子; 大久保 久美子; 川島 博信; 小野 順子; 松永 彰
福岡大学医学紀要, 2012年03月, 39(1):27 - 33

Vancomycin Bactericidal Activity as a Predictor of 30-Day Mortality in Patients with Methicillin-Resistant Staphylococcus aureus Bacteremia
Motoyasu Miyazaki; Tohru Takata; Hisae Yoshimura; Akira Matsunaga; Daiki Ohta; Hiroyasu Ishikura; Maki Futo; Shuji Hara; Hidetoshi Kamimura; Kazuo Tamura; Dung Ngo; Brian T. Tsuji
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2011年04月, 55(4):1819 - 1820

研究機関研究所近況 産学官連携研究機関 心臓・血管研究所 福岡大学産学官連携研究機関「心臓・血管研究所（心研）」の紹介
朔啓二郎; 田代忠; 岩崎昭憲; 立花克郎; 松永彰; 出石宗仁
Research, 2011年, :23 - 25

PE-400 HDL-Raising Efficacy and the Effects of ROSuvastatin on Small, Dense Electronegative LDL as Characterized by CapillARY Isotachophoresis : The ROSARY Study(PE067,Lipid Disorders 1 (H),Poster Session (English),The 73rd Annual Scientific Meeting of the Japanese Circulation Society)
Zhang Bo; Matsunaga Akira; Miura Shinichiro; Noda Keita; Nishikawa Hiroaki; Uehara Yoshinari; Shirai Kazuyuki; Ogawa Masahiro; Saku Keijiro
Circulation journal : official journal of the Japanese Circulation Society, 2009年03月01日, 73:500 - 501

PE-354 Effect of Pitavastatin on Apolipoprotein A5 Secretion in HepG2 Cells(Lipid disorders(03)(H),Poster Session(English),The 72nd Annual Scientific Meeting of the Japanese Circulation Society)
Arishima Hiroaki; Matsunaga Akira; Niimura Hideya; Zhang Bo; Ohwaki Kazuo; Saku Keijiro
Circulation journal : official journal of the Japanese Circulation Society, 2008年03月01日, 72:448 - 448

PJ-721 Comparison of LDL Subclasses as Analyzed by Quantitative Ultracentrifugation, Nuclear Magnetic Resonance Spectroscopy and Capillary Isotachophoresis(Lipid disorders(04)(H),Poster Session(Japanese),The 72nd Annual Scientific Meeting of the Japanese Circulation Society)
Zhang Bo; Matsunaga Akira; Noda Keita; Miura Shinichiro; Hattori Hiroaki; Nishikawa Hiroaki; Saku Keijiro
Circulation journal : official journal of the Japanese Circulation Society, 2008年03月01日, 72:693 - 693

Fast-migrating low-density lipoprotein as analyzed by capillary isotachophoresis is related to inflammatory markers and reduced by pravastatin and simvastatin: The SPECIAL study
Bo Zhanq; Shin-Chiro Miura; Keita Noda; Hiroaki Nishkawa; Akira Matsunaga; Kazuyuki Shirai; Atsushi Iwata; Keijiro Saku
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008年03月, 51(10):A331 - A332

PJ-516 Apolipoprotein A5 Gene Polymorphisms, -1131T>C and c.553G>T were in Strong Linkage Disequilibria and Associated with Hypertriglyceridemia in Japanese(Lipid disorders-3, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
Matsunaga Akira; Arishima Hiroaki; Niimura Hideya; Zhang Bo; Uehara Yoshinari; Saku Keijiro
Circulation journal : official journal of the Japanese Circulation Society, 2007年03月01日, 71:601 - 601

Apolipoprotein A5 gene polymorphisms, -1131T > C and c.553G > T were in strong linkage disequilibria and associated with hypertriglyceridemia in Japanese
A. Matsunaga; H. Arishima; Y. Uehara; B. Zhang; H. Niimura; K. Saku
ATHEROSCLEROSIS SUPPLEMENTS, 2006年06月, 7(3):396 - 396

Effects of pitavastatin for expression of the apolipoprotein A5 in HepG2 cell
A. Matsunaga; H. Arishima; Y. Uehara; B. Zhang; H. Niimura; K. Saku
ATHEROSCLEROSIS SUPPLEMENTS, 2006年06月, 7(3):570 - 571

Clinical significance of the coronary calcification score by multi-detector row computed tomography for the evaluation of coronary stenosis
R. Mitsutake; H. Niimura; S. Miura; B. Zhang; A. Iwata; H. Nishikawa; K. Kumagai; K. Shirai; A. Matsunaga; K. Saku
ATHEROSCLEROSIS SUPPLEMENTS, 2006年06月, 7(3):268 - 268

PJ-242 Pitavastatin Upregulates the Expression of the Apolipoprotein A5 in HepG2 Cell(Lipid disorders-3 (H) PJ41,Poster Session (Japanese),The 70th Anniversary Annual Scientific Meeting of the Japanese Circulation Society)
Arishima Hiroaki; Matsunaga Akira; Niimura Hideya; Zhang Bo; Uehara Yoshinari; Saku Keijiro
Circulation journal : official journal of the Japanese Circulation Society, 2006年03月01日, 70:549 - 550

冠動脈CT検査にてソフトプラークの安定化を確認し得た一例(第98回日本循環器学会九州地方会)
光武 良晃; 新村 英也; 三浦 伸一郎; 松永 彰; 朔 啓二郎
Circulation journal : official journal of the Japanese Circulation Society, 2005年10月20日, 69:988 - 988

スポーツ腎症と横紋筋融解症に見られる急性腎不全の遺伝子解析とマススクリーニング.
兼岡秀俊; 向野義人; 松永彰
Research, 2005年09月, 10(3):39 - 40

Characteristics of Brugada Syndrome with Atrial Fibrillation(Arrhythmia, Diagnosis/Pathophysiology/EPS 9 (A), The 69th Annual Scientific Meeting of the Japanese Circulation Society)
Ogawa Masahiro; Kumagai Koichiro; Noguchi Hiroo; Yasuda Tomoo; Niimura Hideya; Takashima Hideo; Hayashi Chiharu; Muraoka Soichi; Matsunaga Akira; Saku Keijiro
Circulation journal : official journal of the Japanese Circulation Society, 2005年03月01日, 69:225 - 225

Apolipoprotein A-V Gene Polymorphisms, G185C and-1131T>C Associated with Hypertriglyceridemia in Western Japanese Population(Lipid Disorders 4 (H), The 69th Annual Scientific Meeting of the Japanese Circulation Society)
Matsunaga Akira; Niimura Hideya; Zhang Bo; Arishima Hiroaki; Ohwaki Kazuo; Saku Keijiro
Circulation journal : official journal of the Japanese Circulation Society, 2005年03月01日, 69:496 - 496

Detection and Quantification of Potentially Atherogenic Triglyceride-Rich Remnant Lipoprotein Subfraction Using Capillary Isotachophoresis(Lipid Disorders 1 (H), The 69th Annual Scientific Meeting of the Japanese Circulation Society)
Zhang Bo; Fan Ping; Imaizumi Satoshi; Noda Keita; Matsunaga Akira; Saku Keijiro
Circulation journal : official journal of the Japanese Circulation Society, 2005年03月01日, 69:361 - 362

Relation between Remnant-like Particle Fraction and Electronegative Low-Density Lipoprotein Subfraction in Patients with Hypercholesterolemia(Atherosclerosis, Clinical 14 (IHD), The 69th Annual Scientific Meeting of the Japanese Circulation Society)
Zhang Bo; Imaizumi Satoshi; Noda Keita; Matsunaga Akira; Saku Keijiro
Circulation journal : official journal of the Japanese Circulation Society, 2005年03月01日, 69:253 - 254

Frequencies of apolipoprotein A-V polymorphisms ApoA-V (G185C) and-1131T > C in patients with hypertriglyceridemia
A Matsunaga; H Niimura; H Arishima; K Ohwaki; K Yonemura; K Saku
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005年02月, 45(3):385A - 385A

Charge-based major low-density lipoprotein subfiraction associated with Alzheimer's disease and mild cognitive impairment
B Zhang; S Nakano; A Matsunaga; T Yamada; K Saku
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005年02月, 45(3):422A - 422A

Genetic analysis of Brugada syndrome in western Japan - Two novel mutations (vol 68, pg 740, 2004)
H Niimura; A Matsunaga; K Kumagai; K Ohwaki; M Ogawa; H Noguchi; K Yonemura; K Saku
CIRCULATION JOURNAL, 2004年10月, 68(10):974 - 974

家族性高脂血症への対応 (特集 日常病にどう対応しますか?--頻度順に考える症状/疾病の対処法) -- (その他で比較的多い健康問題の対応)
松永 彰; 朔 啓二郎
治療, 2004年03月, 86:1382 - 1384

Angiotensin-converting enzyme (ACE) inhibitor prevents restenosis after coronary stent implantation
K Ohwaki; A Matsunaga; H Niimura; K Yonemura; K Saku
ATHEROSCLEROSIS SUPPLEMENTS, 2003年09月, 4(2):325 - 325

14)心不全の原因となるnon protected LMTに対するinterventionの1例
今泉 聡; 土屋 芳弘; 安田 智生; 村上 謹士郎; 新村 英也; 西川 宏明; 大脇 和男; 三浦 伸一郎; 松尾 邦浩; 松永 彰; 朔 啓二郎
Circulation journal : official journal of the Japanese Circulation Society, 2003年04月20日, 67:868 - 868

Fenofibrate and Pitavastatin Increase Transcriptional Levels of Apolipoprotein A-I Gene Variants at 5' Untranlation Region
Matsunaga Akira; Niimura Hideya; Ohwaki Kazuo; Saku Keijiro
Circulation journal : official journal of the Japanese Circulation Society, 2003年03月01日, 67:270 - 270

A Novel Mutation of Human Apolipoprotein A-V Gene, ApoA-V (Gly162Cys) : Influence of the Mutation on High Plasma Triglyceride Levels
Niimura Hideya; Matsunaga Akira; Ohwaki Kazuo; Saku Keijiro
Circulation journal : official journal of the Japanese Circulation Society, 2003年03月01日, 67:270 - 270

93)劇症型心筋炎を救命し得た一例(日本循環器学会 第91回九州地方会)
杉原 充; 小田 晋也; 山之内 良雄; 松永 彰; 朔 啓二郎
Circulation journal : official journal of the Japanese Circulation Society, 2002年04月20日, 66:994 - 994

73) 洞機能不全症候群を合併した若年型ceroid lipofuscinosis の一例
横山 圭二; 東條 秀明; 芹川 威; 野口 博生; 蒲地 英之; 山之内 良雄; 熊谷 浩一郎; 松永 彰; 野田 慶太; 出石 宗仁; 朔 啓二郎; 満留 昭久
Japanese circulation journal, 2001年04月20日, 65:692 - 692

Development of human-chymase-overexpressed mice showing chronic inflammation and aortic lipid deposition after high cholesterol diet
T Koga; H Urata; A Matsunaga; J Sasaki; M Ideishi; K Arakawa
JOURNAL OF HYPERTENSION, 2000年, 18:S91 - S91

Human chymase overexpression in mice induces weight loss, hypocholesterolemia, leukocytosis and tachycardia
T Koga; H Urata; A Matsunaga; J Sasaki; M Ideishi; K Arakawa
CIRCULATION, 1999年11月, 100(18):813 - 813

アポ蛋白遺伝子多型から
松永 彰; 佐々木 淳
動脈硬化 = The journal of Japan Atherosclerosis Society, 1998年06月15日, 25(8):315 - 318

Characterization of apolipoprotein E3-Nanakuma (Ala214->Val): An new apolipoprotein E3 variant detected by single strand conformation polymorphism
A Matsunaga; J Sasaki; M Kugi; T Koga; K Arakawa
ATHEROSCLEROSIS, 1997年10月, 134(1-2):71 - 72

Apolipoprotein E Sendai (145 arginine->proline): A new variant with lipoprotein glomerulopathy.
S Oikawa; A Matsunaga; T Saito; H Sato; K Hoshi; K Abe; K Kudo; T Toyota; J Sasaki
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1996年09月, 7(9):A1852 - A1852

Apolipoprotein E ε4
S. Sakoda; M. Kuriyama; M. Osame; K. Takahashi; T. Yamano; J. Sasaki; A. Matsunaga
Neurology, 1994年, 44(12):2420

APOLIPOPROTEIN-(APO)-E 2 FUKUOKA - ARG224-]GIN AND APO-E1-LYS146-]GLU WITH TYPE-III HYPERLIPOPROTEINEMIA - SCREENING OF APO-E VARIANTS USING COMBINED ISOELECTRIC-FOCUSING AND RESTRICTION-FRAGMENT-LENGTH-POLYMORPHISM OF APO-E GENE
K MORIYAMA; A MATSUNAGA; K ARAKI; Y TAKADA; J SASAKI; K ARAKAWA
CIRCULATION, 1992年10月, 86(4):421 - 421

DECREASED ARACHIDONIC-ACID CONTENT AND METABOLISM IN TISSUES OF NZB-W F1 FEMALES FED A DIET CONTAINING 0.45-PERCENT DEHYDROISOANDROSTERONE (DHA)
A MATSUNAGA; GL COTTAM
FEDERATION PROCEEDINGS, 1987年05月, 46(6):2177 - 2177

Apolipoprotein A-I Mutations and Clinical Evaluation. In: The HDL Handbook (Second Edition)
Akira Matsunaga, 分担執筆, Apolipoprotein A-I Mutations and Clinical Evaluation
London, Academic Press (Elsevier), 2014年

Apolipoprotein A-I mutations. In: The HDL handbook: Biological functions and clinical implications.
Matsunaga A; Uehara Y; Zhang B; Saku K; Tsugikazu Komoda ed, 共著
London, Academic Press (Elsevier), 2010年

Glomerular lipidosis associated with massive macrophages infiltration in a patient with apo E phenotype E3/3
Sasatomi Y; Watanabe M; Ito K; AbeY; Ogahara S; Hisano H; Matsunaga A; Nakashima H; Saito T
WCN 2013 Satellite Symposium "Kidney and Lipids", 2013年06月06日

Polymorphism of apolipoprotein E (apoE) variants in lipoprotein glomerulopathy (LPG).
Takao Saito; Akira Matsunaga; Kenji Ito; Maho Watanabe; Hitoshi Nakashima
Worald Congress of Nephrology 2011, 2011年04月

2008年09月 - 現在
日本臨床化学会

日本循環器学会

日本内科学会

日本臨床検査医学会

日本動脈硬化学会

高TG,低HDL血症を中心とした脂質異常症関連遺伝子解析
日本学術振興会, 科学研究費助成事業, 基盤研究(C)
福岡大学
2016年04月01日 - 2019年03月31日

ｃＩＴＰ法を用いたリポ蛋白分析から脂質異常症の病態・生理・機能を解明する
日本学術振興会, 科学研究費助成事業, 基盤研究(C)
福岡大学
2011年04月28日 - 2015年03月31日

遺伝子多型によるヒトアポA-Iの発現制御と高脂血症治療薬に対する反応に関する研究
日本学術振興会, 科学研究費助成事業, 基盤研究(C)
福岡大学
2002年 - 2004年

ヒトキマーゼの各種心血管病態でのin vivo機能解析
日本学術振興会, 科学研究費助成事業, 基盤研究(B)
福岡大学
2001年 - 2003年

新規変性LDLとしての糖酸化LDLの粥状硬化巣における形成とその役割
日本学術振興会, 科学研究費助成事業, 基盤研究(C)
福岡大学
1998年 - 2001年

リポ蛋白糸球体症のモデル動物作製と病態解析
日本学術振興会, 科学研究費助成事業, 基盤研究(C)
福岡大学
1999年 - 2000年

アポ蛋白A-I遺伝子変異のコレステロール逆転送経路に及ぼす影響
日本学術振興会, 科学研究費助成事業, 基盤研究(C)
福岡大学
1996年 - 1997年

アポ蛋白E遺伝子変異とリポ蛋白系球体症に関する研究
日本学術振興会, 科学研究費助成事業, 基盤研究(C)
福岡大学
1996年 - 1997年

リポ蛋白によるマクロファージからのアラキドン酸代謝産物放出における研究
日本学術振興会, 科学研究費助成事業, 奨励研究(A)
福岡大学
1992年 - 1992年

血管平滑筋細胞及びマクロファージのプロスタグランジン放出における研究
日本学術振興会, 科学研究費助成事業, 奨励研究(A)
福岡大学
1991年 - 1991年

リポ多糖体(LPS)前処理マクロファージのアラキドン酸代謝物放出における研究
日本学術振興会, 科学研究費助成事業, 奨励研究(A)
福岡大学
1990年 - 1990年

Prolineーrich proteinの構造と構能及び臨床的意義
日本学術振興会, 科学研究費助成事業, 一般研究(C)
福岡大学
1988年 - 1990年